PROTACs: emerging targeted protein degradation approaches for advanced druggable strategies

NI Sincere, K Anand, S Ashique, J Yang, C You - Molecules, 2023 - mdpi.com
A potential therapeutic strategy to treat conditions brought on by the aberrant production of a
disease-causing protein is emerging for targeted protein breakdown using the PROTACs …

Towards a New Paradigm for Digital Health Training and Education in Australia: Exploring the Implication of the Fifth Industrial Revolution

TY Pang, TK Lee, M Murshed - Applied Sciences, 2023 - mdpi.com
Featured Application This paper presents a new, fifth industrial revolution (Industry 5.0)-
inspired paradigm for educating and training Australian healthcare professionals and …

[HTML][HTML] Digital Frontiers in Healthcare: Integrating mHealth, AI, and Radiology for Future Medical Diagnostics

R Najjar - 2024 - intechopen.com
In an era where technology and healthcare increasingly intertwine, we stand on the
precipice of a seismic shift in the future of healthcare and medicine. This chapter unravels …

In vivo CAR T cells and targeted gene delivery: A theme for the Pharmaceuticals and Medical Devices Agency Science Board to address

R Wakao, A Fukaya-Shiba - Frontiers in Medicine, 2023 - frontiersin.org
3. Discussion Intensive efforts have been focused on engineering CAR T cells directly in
vivo to bypass ex vivo manipulation. While these innovative products offer clinical …

Implementing Horizon Scanning as a tool for the strategic development of regulatory guidelines for nanotechnology-enabled health products

FD Rodríguez-Gómez, D Monferrer, O Penon… - Frontiers in …, 2024 - frontiersin.org
Strategic regulatory development is essential to ensure that new innovations in
nanotechnology-enabled health products (NHPs) successfully reach the market and benefit …

Insights into implementation planning for point-of-care testing to guide treatment of chronic obstructive pulmonary disease exacerbation: a mixed methods feasibility …

J Hart, AD Edwards, A Stainthorpe - Frontiers in health services, 2024 - frontiersin.org
The purpose of this mixed methods feasibility study was to gain insights into unmet clinical
needs, stakeholder preferences and potential barriers and enablers to adoption for planning …

EMERGINCaRE, le dispositif d'horizon scanning dédié aux médicaments anticancéreux développé par l'Institut national du cancer

M Duperray, C Bertin, L Sagot, T Breton, N Ifrah - Bulletin du Cancer, 2024 - Elsevier
Résumé Introduction Dans un contexte d'innovation et de développements cliniques
intenses en oncologie, l'Institut national du cancer a développé depuis 2019, un horizon …

[HTML][HTML] Глобальный спектр разработки инновационных лекарственных препаратов: описательный обзор

ВА Меркулов, РИ Ягудина… - Ведомости Научного …, 2024 - cyberleninka.ru
АКТУАЛЬНОСТЬ. Быстрый рост ассортимента лекарственных средств глобального
фармацевтического рынка предопределяет актуальность периодического обзора …

[PDF][PDF] METHODOLOGICAL APPROACHES TO ASSESSING DIGITAL MATURITY OF LOGISTICS ACTIVITIES OF PHARMACEUTICAL ENTERPRISES.

A Lisna, O Posilkina, O Litvinova… - ScienceRise …, 2023 - pdfs.semanticscholar.org
Materials and methods: Research was conducted using databases on the Internet: the
European Center for Information Systems Research, the European Medicines Agency, and …

Проблеми створення ефективної системи оцінки медичних технологій на ранніх етапах життєвого циклу лікарських засобів

VM Nazarkina, AS Nemchenko… - Social Pharmacy in …, 2024 - sphhcj.nuph.edu.ua
Aim. To study modern approaches to the formation and functioning of the Horizon Scanning
(HS) system and early health technology assessment (HTА), in particular, for the treatment of …